424B5

Prospectus

Aldeyra Therapeutics, Inc. Filed 2016-05-25 Acc 0001193125-16-602245

Documents 1

424B5 Prospectus , d160912d424b5.htm

Around this filing

2016-05-27 8-K Material agreement · Other events
2016-05-27 424B5 Prospectus
2016-05-26 4 10% owner bought 700,000 shares at $5.00 ($3,500,000)
2016-05-25 424B5 Prospectus

Link to a passage

External

SEC EDGAR (opens in new tab)